| Literature DB >> 35564640 |
Miłosz Czuba1,2, Kamila Płoszczyca3, Katarzyna Kaczmarczyk1, Józef Langfort2, Robert Gajda4,5.
Abstract
The aim of this study was to analyze the effects of the "live high, train low" method (LH-TL) and intermittent hypoxic training (IHT) on testosterone (T) and cortisol (C) levels in cyclists. Thirty cyclists participated in the experiment. The LH-TL group (n = 10) was exposed to normobaric hypoxia (FiO2 = 16.3%) for 11-12 h a day and trained in normoxia for 3 weeks. In the IHT group (n = 10), participants followed the IHT routine three times a week for 3 weeks in normobaric hypoxia (FiO2 = 16.3%). The control group (N; n = 10) followed the same training protocol in normoxia. The LH-TL training was found to significantly increase (p < 0.05) T levels and the testosterone/cortisol (T/C) ratio during the experiment. The area under the curve (AUC) calculated for T levels over 4 weeks was significantly (p < 0.05) higher in the LH-TL group, by 25.6%, compared to the N group. The results also indicated a significant correlation (r = 0.53; p < 0.05) between AUC for T levels over 4 weeks and ∆ values of hemoglobin (HGB) in the LH-TL group. Overall, the findings show that LH-TL training at a moderate simulated altitude contributes to an increase in T levels and T/C ratio in athletes, which is a beneficial change stimulating anabolic processes and erythropoiesis.Entities:
Keywords: altitude training; anabolic–catabolic response; cortisol; hypoxia; testosterone
Mesh:
Substances:
Year: 2022 PMID: 35564640 PMCID: PMC9102561 DOI: 10.3390/ijerph19095246
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Characteristics of the study participants (mean ± SD).
| LH–TL | IHT | N | Results of One-Way ANOVA | |
|---|---|---|---|---|
| Age (y) | 20.5 ± 2.9 | 20.7 ± 3.1 | 21.8 ± 4.0 | F = 0.230 |
| Height (cm) | 181 ± 4.3 | 178.0 ± 5.3 | 178.2 ± 3.4 | F = 1.750 |
| Weight (kg) | 69.6 ± 3.9 | 67.5 ± 5.3 | 68.1 ± 4.8 | F = 0.442 |
| FAT (%) | 8.4 ± 2.6 | 10.6 ± 2.0 | 8.4 ± 2.4 | F = 2.903 |
| VO2max (mL/kg/min) | 66.0 ± 4.1 | 67.6 ± 2.7 | 67.0 ± 2.9 | F = 0.541 |
| WRLT (W) | 292 ± 21.4 | 286.0 ± 25.0 | 280 ± 21.1 | F = 2.154 |
Abbreviations: FAT—body fat content; VO2max—maximal oxygen consumption; WRLT—workload at lactate threshold.
Training program during the experiment.
| Day | Microcycle 1 | Microcycle 2 | Microcycle 3 | Microcycle 4 |
|---|---|---|---|---|
| 1 | T1 + 2 h endurance training (60–75% of WRLT) | T2 + 2 h endurance training (60–75% of WRLT) | T3 + 2 h endurance training (60–75% of WRLT) | Day off |
| 2 | 3–4 h of endurance training 60–75% of WRLT with high-speed intervals (2 × 6 × 10 s-max) | 3–4 h of endurance training 60–75% of WRLT with high-speed intervals (2 × 6 × 10 s-max) | 3–4 h of endurance training 60–75% of WRLT with high-speed intervals (2 × 6 × 10 s-max) | 1 h active recovery ride < 55% WRLT |
| 3 | T1 + 2 h endurance training (60–75% of WRLT) | T2 + 2 h endurance training (60–75% of WRLT) | T3 + 2 h endurance training (60–75% of WRLT) | 2 h of endurance training 60–75% of WRLT with high-speed intervals (2 × 6 × 10 s-max) |
| 4 | Strength endurance (gym) | Strength endurance (gym) | Strength endurance (gym) | Strength endurance (gym) |
| 5 | T1 + 2 h endurance training (60–75% of WRLT) | T2 + 2 h endurance training (60–75% of WRLT) | T3 + 2 h endurance training (60–75% of WRLT) | T1 + 1 h endurance training (60–75% of WRLT) |
| 6 | 3–4 h of endurance training 60–75% of WRLT with high-speed intervals (2 × 6 × 10 s-max) | 3–4 h of endurance training 60–75% of WRLT with high-speed intervals (2 × 6 × 10 s-max) | 3–4 h of endurance training 60–75% of WRLT with high-speed intervals (2 × 6 × 10 s-max) | 2 h of endurance training 60–75% of WRLT |
| 7 | Day off | Day off | Day off | Day off |
Abbreviations: T1—training in the laboratory (15 min of warm-up (65–70% WRLT/WRLThyp ), 100% WRLT/WRLThyp for 30 min and 15 min of cool-down at 65–75% WRLT/WRLThyp; T2—training in the laboratory (15 min of warm-up (65–70% WRLT/WRLThyp ), 100% WRLT/WRLThyp for 35 min and 15 min of cool-down at 65–70% WRLT/WRLThyp; T3—training in the laboratory (15 min of warm-up (65–70% WRLT/WRLThyp ), 100% WRLT/WRLThyp for 40 min and 15 min of cool-down at 65–70% WRLT/WRLThyp.
Figure 1Blood serum testosterone levels (T) in experimental (LH–TL and IHT) and control (N) groups during the first experiment; ** p < 0.01—statistically significant differences compared to baseline.
Figure 2Blood serum cortisol levels (C) in experimental (LH–TL and IHT) and control (N1) groups during the first experiment.
Figure 3Blood serum testosterone/cortisol ratio (T/C) in experimental (LH–TL and IHT) and control (N) groups during the experiment; ** p < 0.01—statistically significant differences compared to baseline.
Figure 4Area under the curve (AUC) calculated from testosterone levels over 4 weeks in experimental (LH–TL and IHT) and control (N) groups; * p < 0.05—statistically significant differences.
Training load and changes in selected biochemical indices in the study groups (LH–TL, IHT, and N) during the first experiment; * p < 0.05—statistically significant differences compared to baseline.
| Variables | Group | Measurement | ||||
|---|---|---|---|---|---|---|
| Baseline | 1 Week | 2 Weeks | 3 Weeks | 4 Weeks | ||
| Training | LH–TL | 462 ± 35 | 1094 * ± 63 | 1147 * ± 73 | 1283 * ± 69 | 412 ± 27 |
| IHT | 451 ± 25 | 1128 * ± 49 | 1164 * ± 69 | 1276 * ± 76 | 387 ± 22 | |
| N | 434 ± 29 | 1152 * ± 51 | 1194 * ± 76 | 1308 * ± 86 | 426 ± 31 | |
| CK (U/I) | LH–TL | 90.1 ± 34.3 | 139.3 ± 48.9 | 159.7 * ± 58.3 | 161.7 * ± 62.1 | 98.7 ± 27.7 |
| IHT | 110.9 ± 32.1 | 151.8 ± 52.6 | 168.1 * ± 64.1 | 175.1 * ± 52.7 | 115.8 ± 34.1 | |
| N | 89.3 ± 28.4 | 147.2 * ± 42.6 | 158.8* ± 49.4 | 161.7 * ± 55.7 | 108.4 ± 32.2 | |
| URIC (mg/dL) | LH–TL | 4.75 ± 0.34 | 4.98 ± 0.24 | 5.65 * ± 0.26 | 5.81 * ± 0.31 | 4.79 ± 0.34 |
| IHT | 4.83 ± 0.29 | 5.12 ± 0.34 | 5.74 * ± 0.38 | 5.97 * ± 0.42 | 4.89 ± 0.29 | |
| N | 4.91 ± 0.38 | 5.21 ± 0.41 | 5.84 * ± 0.46 | 6.01 * ± 0.52 | 4.87 ± 0.31 | |
Abbreviations: CK—creatine kinase, URIC—uric acid.
Selected hematological variables in the experimental LH–TL group during initial and final evaluations; * p < 0.05, ** p < 0.01—statistically significant differences compared to the baseline values.
| Variable | Baseline | After 4 Weeks | ∆ |
|---|---|---|---|
| RBC (million/μL) | 5.01 ± 0.2 | 5.33 ** ± 0.23 | 0.32 ± 0.19 |
| HGB (g/dL) | 15.3 ± 0.67 | 16.3 ** ± 0.76 | 1.0 ± 0.27 |
| HCT (%) | 44.5 ± 2.3 | 46.5 ** ± 2.5 | 2.0 ± 1.08 |
| Ret (%) | 1.00 ± 0.19 | 1.38 * ± 0.13 | 0.38 ± 0.2 |
Abbreviations: RBC—red blood cell count; HGB—hemoglobin concentration; HCT—hematocrit; Ret—blood reticulocyte percentage.
Figure 5Correlation between area under the curve (AUC) for testosterone levels over 4 weeks (AUC testosterone) and delta values of hemoglobin concentration (∆HGB) during the experiment in the LH–TL group.